Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022108

Expand all

APLENZIN (BUPROPION HYDROBROMIDE)
174MG Marketing Status: Prescription

Active Ingredient: BUPROPION HYDROBROMIDE
Proprietary Name: APLENZIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 174MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022108
Product Number: 001
Approval Date: Apr 23, 2008
Applicant Holder Full Name: VALEANT PHARMACEUTICALS NORTH AMERICA LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

APLENZIN (BUPROPION HYDROBROMIDE)
348MG Marketing Status: Prescription

Active Ingredient: BUPROPION HYDROBROMIDE
Proprietary Name: APLENZIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 348MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022108
Product Number: 002
Approval Date: Apr 23, 2008
Applicant Holder Full Name: VALEANT PHARMACEUTICALS NORTH AMERICA LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

APLENZIN (BUPROPION HYDROBROMIDE)
522MG Marketing Status: Prescription

Active Ingredient: BUPROPION HYDROBROMIDE
Proprietary Name: APLENZIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 522MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N022108
Product Number: 003
Approval Date: Apr 23, 2008
Applicant Holder Full Name: VALEANT PHARMACEUTICALS NORTH AMERICA LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English